A Prospective Observational Study to Evaluate Incidence of Thromboembolic Events during Platinum Based Chemotherapy in Lung Cancer

被引：0
|
作者：
Talreja, V. [1 ]
Joshi, A. [1 ]
Noronha, V. [1 ]
Patil, V. [1 ]
Prabhash, K. [2 ]
Kate, S. [1 ]
机构：
[1] Tata Mem Hosp, Med Oncol, Mumbai, Maharashtra, India
[2] Tata Mem Hosp, Med Oncol, Mumbai, Maharashtra, India
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
thromboembolic events; platinum chemotherapy; prospective;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.03-021
引用
收藏
页码：S1957 / S1958
页数：2
相关论文
共 50 条
  • [41] Delays During Diagnosis and Management of Lung Cancer in India- A Prospective Observational Study
    Garg, A.
    Mohan, A.
    Gupta, A.
    Sahu, S.
    Choudhari, C.
    Arora, S.
    Jain, D.
    Kumar, R.
    Bhalla, A.
    Pandey, R. M.
    Tiwari, P.
    Mittal, S.
    Madan, K.
    Khilnani, G. C.
    Hadda, V.
    Guleria, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [42] Implementation of standardized parenteral nutrition support in cancer patients during chemotherapy: a prospective observational study
    Daum, S.
    Crispin, A.
    Stauder, H.
    Schock, C.
    Schuierer, A.
    Karsten, S.
    Weigand, B.
    Kreuser, E. -D
    ONKOLOGIE, 2010, 33 : 73 - 74
  • [43] Association of Lower Age and Cardiorespiratory Events during Intra-Arterial Chemotherapy for Retinoblastoma: A Prospective Observational Study
    Lima, M. F.
    Teixeira, L. F.
    Teruya, S. B. d. M.
    Macedo, C. R. P. D.
    Pinto, V. M. d. S.
    Terra, T. A.
    Fonseca, J. R. F.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2023, 44 (07) : 828 - 832
  • [44] A PROSPECTIVE OBSERVATIONAL PHARMACOVIGILANCE STUDY TO EVALUATE INCIDENCE, ONSET, AND SEVERITY OF ADVERSE EFFECTS DURING ANTI-TUBERCULAR THERAPY
    Agrawal, A.
    VALUE IN HEALTH, 2016, 19 (03) : A110 - A110
  • [45] A Prospective Observational Pharmacovigilance Study to Evaluate Incidence, Onset and Severity of Adverse Effects During Anti-Tubercular Therapy
    Agrawal, Akhil Bharat
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 435 - 436
  • [46] Markers of response to platinum-based chemotherapy in lung cancer
    Barr, Martin P.
    MacDonagh, Lauren
    O'Byrne, Kenneth J.
    LUNG CANCER MANAGEMENT, 2013, 2 (03) : 227 - 239
  • [47] Thromboembolic events in COVID-19 ambulatory patients: An observational study about incidence, and thromboprophylaxis outcomes
    Hammami, Rania
    Jdidi, Jihen
    Chakroun, Olfa
    Issaoui, Fadhila
    Ktata, Nouha
    Maamri, Hanen
    Baklouti, Mouna
    Bahloul, Amine
    Gargouri, Rania
    Nasri, Abdennour
    Msaad, Sameh
    Kammoun, Samy
    Kammoun, Samir
    Ben Rejab, Imen
    Charfeddine, Selma
    Abid, Leila
    PLOS ONE, 2022, 17 (08):
  • [48] Thromboembolic events (TE) in patients with metastatic non small cell lung cancer (NSCLC) EGFR/ALK native treated with first-line platinum-based chemotherapy
    Castellon Rubio, V. E.
    Luque Caro, R.
    Gonzalez Flores, E.
    Canosa Ruiz, L.
    ANNALS OF ONCOLOGY, 2015, 26 : 116 - 116
  • [49] Incidence of lung cancer in smokers with and without COPD: Observational study
    Moya, Virginia
    Boldova, Ana
    Forcen, Elena
    Minchole, Elisa
    Maria Marin, Jose
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [50] NADROPARIN FOR THE PREVENTION OF THROMBOEMBOLIC EVENTS IN AMBULATORY PATIENTS WITH LUNG CANCER RECEIVING CHEMOTHERAPY: A TREATMENT-BASED SUB-GROUP ANALYSIS OF THE PROTECHT STUDY
    Verso, M.
    Mandala, M.
    Barni, S.
    Labianca, R.
    Gasparini, G.
    Cavanna, L.
    Passalacqua, R.
    Tonato, M.
    Gussoni, G.
    Agnelli, G.
    ANNALS OF ONCOLOGY, 2010, 21 : 395 - 396
12345